JP2011507946A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507946A5 JP2011507946A5 JP2010540226A JP2010540226A JP2011507946A5 JP 2011507946 A5 JP2011507946 A5 JP 2011507946A5 JP 2010540226 A JP2010540226 A JP 2010540226A JP 2010540226 A JP2010540226 A JP 2010540226A JP 2011507946 A5 JP2011507946 A5 JP 2011507946A5
- Authority
- JP
- Japan
- Prior art keywords
- nanodispersion
- surfactant
- salt
- docetaxel
- paclitaxel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004094 surface-active agent Substances 0.000 claims 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 4
- 229930012538 Paclitaxel Natural products 0.000 claims 4
- 229960003668 docetaxel Drugs 0.000 claims 4
- 239000002105 nanoparticle Substances 0.000 claims 4
- 229960001592 paclitaxel Drugs 0.000 claims 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 4
- 239000002904 solvent Substances 0.000 claims 4
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims 4
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 4
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims 3
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- 108010020346 Polyglutamic Acid Proteins 0.000 claims 3
- BHYOQNUELFTYRT-DPAQBDIFSA-N cholesterol sulfate Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 BHYOQNUELFTYRT-DPAQBDIFSA-N 0.000 claims 3
- 229940080277 cholesteryl sulfate Drugs 0.000 claims 3
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 claims 3
- 229940014041 hyaluronate Drugs 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 229960002446 octanoic acid Drugs 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- CTPDSKVQLSDPLC-UHFFFAOYSA-N 2-(oxolan-2-ylmethoxy)ethanol Chemical compound OCCOCC1CCCO1 CTPDSKVQLSDPLC-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 150000001298 alcohols Chemical group 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 150000002334 glycols Chemical class 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 229920001515 polyalkylene glycol Polymers 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2527MU2007 | 2007-12-24 | ||
| IN2527/MUM/2007 | 2007-12-24 | ||
| PCT/IN2008/000857 WO2009087678A2 (en) | 2007-12-24 | 2008-12-23 | Nanodispersion |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014237028A Division JP5937180B2 (ja) | 2007-12-24 | 2014-11-21 | ナノ分散体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011507946A JP2011507946A (ja) | 2011-03-10 |
| JP2011507946A5 true JP2011507946A5 (OSRAM) | 2013-11-28 |
| JP5656643B2 JP5656643B2 (ja) | 2015-01-21 |
Family
ID=40853553
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010540226A Active JP5656643B2 (ja) | 2007-12-24 | 2008-12-23 | ナノ分散体 |
| JP2014237028A Expired - Fee Related JP5937180B2 (ja) | 2007-12-24 | 2014-11-21 | ナノ分散体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014237028A Expired - Fee Related JP5937180B2 (ja) | 2007-12-24 | 2014-11-21 | ナノ分散体 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8586062B2 (OSRAM) |
| EP (2) | EP2231144B1 (OSRAM) |
| JP (2) | JP5656643B2 (OSRAM) |
| KR (1) | KR101505419B1 (OSRAM) |
| CN (1) | CN101909614B (OSRAM) |
| AP (1) | AP2895A (OSRAM) |
| AU (1) | AU2008346121B2 (OSRAM) |
| BR (1) | BRPI0821514B8 (OSRAM) |
| CA (1) | CA2710525C (OSRAM) |
| CO (1) | CO6290681A2 (OSRAM) |
| DK (1) | DK2231144T3 (OSRAM) |
| EA (1) | EA016434B1 (OSRAM) |
| ES (1) | ES2509490T3 (OSRAM) |
| IL (1) | IL206584A0 (OSRAM) |
| MX (1) | MX2010007076A (OSRAM) |
| NZ (1) | NZ586343A (OSRAM) |
| PL (1) | PL2231144T3 (OSRAM) |
| UA (1) | UA100543C2 (OSRAM) |
| WO (1) | WO2009087678A2 (OSRAM) |
| ZA (1) | ZA201004450B (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8778364B2 (en) * | 2009-06-19 | 2014-07-15 | Sun Pharma Advanced Research Company Ltd. | Nanodispersion of a drug and process for its preparation |
| CN102038635A (zh) * | 2009-10-23 | 2011-05-04 | 天津天士力集团有限公司 | 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法 |
| KR20110056042A (ko) * | 2009-11-20 | 2011-05-26 | 주식회사유한양행 | 종양세포 표적지향을 위한 나노 입자 및 이의 제조방법 |
| JP5824511B2 (ja) | 2010-05-03 | 2015-11-25 | テイコク ファーマ ユーエスエー インコーポレーテッド | 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法 |
| ES2385995B2 (es) * | 2011-01-10 | 2013-05-21 | Universidade De Santiago De Compostela | Nanocápsulas con cubierta polimérica |
| CN102078300B (zh) * | 2011-01-27 | 2012-01-11 | 海南美大制药有限公司 | 托拉塞米脂质体固体制剂 |
| CN102366409B (zh) * | 2011-09-14 | 2013-03-20 | 海南灵康制药有限公司 | 一种尼扎替丁脂质体固体制剂 |
| JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
| BR112015022231B1 (pt) * | 2013-03-14 | 2020-11-24 | Griffith Laboratories International, Inc. | Metodo para tratamento de fungos que causam sigatoka negra em plantaqoes da familia musaceae |
| US20170099833A1 (en) * | 2014-05-30 | 2017-04-13 | Oms Investments, Inc. | Nano-sized water-based dispersion compositions and methods of making thereof |
| KR101692314B1 (ko) * | 2015-03-27 | 2017-01-03 | 주식회사 주빅 | 지용성 약물의 생분해성 고분자 내 용해 시스템: 스마트 폴리머 시스템 |
| US20160346219A1 (en) | 2015-06-01 | 2016-12-01 | Autotelic Llc | Phospholipid-coated therapeutic agent nanoparticles and related methods |
| JP2018516964A (ja) * | 2015-06-09 | 2018-06-28 | サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドＳｕｎ Ｐｈａｒｍａ Ａｄｖａｎｃｅｄ Ｒｅｓｅａｒｃｈ Ｃｏｍｐａｎｙ Ｌｉｍｉｔｅｄ | 局所進行性または転移性である肝内もしくは肝外胆管または胆嚢のカルシノーマに罹患する患者を治療する方法 |
| CN107551390A (zh) * | 2017-08-21 | 2018-01-09 | 常熟佳禾生物科技有限公司 | 一种用于治疗乳腺小叶增生的中药文胸贴片及其制备方法 |
| JP7383626B2 (ja) * | 2018-03-19 | 2023-11-20 | エピクワイティー ファーマ アーべー | カルシウム欠乏に起因する状態の治療に使用するための組成物 |
| US11423574B2 (en) | 2019-12-17 | 2022-08-23 | Emma Ruccio | Method and apparatus for detecting scoliosis |
| US11877717B2 (en) | 2019-12-17 | 2024-01-23 | Emma Ruccio | Method and apparatus for detecting scoliosis |
| EP3928772B1 (en) * | 2020-06-26 | 2024-06-19 | Algiax Pharmaceuticals GmbH | Nanoparticulate composition |
| JP7745863B2 (ja) * | 2021-04-12 | 2025-09-30 | 国立大学法人広島大学 | 難水溶性物質の可溶化方法および難水溶性物質の可溶化組成物 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6018A (en) * | 1849-01-09 | Improvement in bog-cutters | ||
| US5399363A (en) * | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US6753006B1 (en) | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
| US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
| US6458373B1 (en) * | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| KR19990075621A (ko) * | 1998-03-23 | 1999-10-15 | 임성주 | 경사 평판형 배양조 |
| US6017948A (en) * | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
| US6365191B1 (en) * | 1999-02-17 | 2002-04-02 | Dabur Research Foundation | Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| WO2001021174A1 (en) * | 1999-09-23 | 2001-03-29 | Dabur Research Foundation | Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles |
| TWI230616B (en) * | 2000-09-25 | 2005-04-11 | Ind Tech Res Inst | Liposome for incorporating large amounts of hydrophobic substances |
| CA2445763A1 (en) * | 2001-05-01 | 2002-11-07 | Angiotech Pharmaceuticals Inc. | Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
| DE10124952A1 (de) * | 2001-05-21 | 2002-12-12 | Bayer Ag | Verfahren zur Herstellung von Nanodispersionen |
| AU2002357012A1 (en) * | 2001-11-27 | 2003-06-10 | Transform Pharmaceuticals, Inc. | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof |
| US6780324B2 (en) | 2002-03-18 | 2004-08-24 | Labopharm, Inc. | Preparation of sterile stabilized nanodispersions |
| ITMI20022323A1 (it) * | 2002-10-31 | 2004-05-01 | Maria Rosa Gasco | Composizioni farmaceutiche atte al trattamento di malattie oftalmiche. |
| US7670627B2 (en) * | 2002-12-09 | 2010-03-02 | Salvona Ip Llc | pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients |
| US7345093B2 (en) * | 2004-04-27 | 2008-03-18 | Formatech, Inc. | Methods of enhancing solubility of compounds |
| US20050288521A1 (en) * | 2004-06-29 | 2005-12-29 | Phytogen Life Sciences Inc. | Semi-synthetic conversion of paclitaxel to docetaxel |
| MX2007010394A (es) * | 2005-02-24 | 2008-02-19 | Elan Pharma Int Ltd | Formulaciones nanoparticuladas de docetaxel y analogos del mismo. |
| EP2138164A1 (en) | 2005-06-17 | 2009-12-30 | Hospira Australia Pty Ltd | Liquid pharmaceutical formulations of docetaxel |
| CA2626016A1 (en) * | 2005-10-21 | 2007-06-21 | Panacea Biotec Limited | Pharmaceutical composition comprising at least one anticancer drug and at least one polymer |
| KR100917809B1 (ko) * | 2006-05-22 | 2009-09-18 | 에스케이케미칼주식회사 | 우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물 |
| US20100068251A1 (en) * | 2006-10-10 | 2010-03-18 | Jina Pharmaceuticals, Inc. | Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof |
-
2008
- 2008-12-23 AP AP2010005314A patent/AP2895A/xx active
- 2008-12-23 CA CA2710525A patent/CA2710525C/en active Active
- 2008-12-23 WO PCT/IN2008/000857 patent/WO2009087678A2/en not_active Ceased
- 2008-12-23 ES ES08870171.9T patent/ES2509490T3/es active Active
- 2008-12-23 NZ NZ586343A patent/NZ586343A/en not_active IP Right Cessation
- 2008-12-23 EP EP08870171.9A patent/EP2231144B1/en active Active
- 2008-12-23 EP EP14175007.5A patent/EP2853264A1/en not_active Withdrawn
- 2008-12-23 BR BRPI0821514A patent/BRPI0821514B8/pt active IP Right Grant
- 2008-12-23 CN CN200880122577.2A patent/CN101909614B/zh active Active
- 2008-12-23 MX MX2010007076A patent/MX2010007076A/es active IP Right Grant
- 2008-12-23 US US12/810,428 patent/US8586062B2/en not_active Expired - Fee Related
- 2008-12-23 PL PL08870171T patent/PL2231144T3/pl unknown
- 2008-12-23 KR KR1020107014449A patent/KR101505419B1/ko not_active Expired - Fee Related
- 2008-12-23 JP JP2010540226A patent/JP5656643B2/ja active Active
- 2008-12-23 UA UAA201009239A patent/UA100543C2/ru unknown
- 2008-12-23 AU AU2008346121A patent/AU2008346121B2/en active Active
- 2008-12-23 EA EA201070793A patent/EA016434B1/ru not_active IP Right Cessation
- 2008-12-23 DK DK08870171.9T patent/DK2231144T3/da active
-
2010
- 2010-06-23 ZA ZA2010/04450A patent/ZA201004450B/en unknown
- 2010-06-23 IL IL206584A patent/IL206584A0/en unknown
- 2010-07-22 CO CO10089145A patent/CO6290681A2/es not_active Application Discontinuation
-
2013
- 2013-10-03 US US14/045,250 patent/US20140030352A1/en not_active Abandoned
-
2014
- 2014-11-21 JP JP2014237028A patent/JP5937180B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Teodorescu et al. | Poly (vinylpyrrolidone)–a versatile polymer for biomedical and beyond medical applications | |
| Shin et al. | Tannic acid as a degradable mucoadhesive compound | |
| Amgoth et al. | Polymer properties: Functionalization and surface modified nanoparticles | |
| Naskar et al. | Solution behavior of normal and reverse triblock copolymers (Pluronic L44 and 10R5) individually and in binary mixture | |
| Li et al. | Self-assembly and applications of poly (glycidyl methacrylate) s and their derivatives | |
| Yin et al. | A fluorescent core− shell dendritic macromolecule specifically stains the extracellular matrix | |
| JP2013534981A5 (OSRAM) | ||
| Rajamalli et al. | Metal induced gelation from pyridine cored poly (aryl ether) dendrons with in situ synthesis and stabilization of hybrid hydrogel composites | |
| JP2012514682A5 (OSRAM) | ||
| Nguyen et al. | Reverse micelles prepared from amphiphilic polylactide-b-poly (ethylene glycol) block copolymers for controlled release of hydrophilic drugs | |
| Ye et al. | A pH‐Sensitive Injectable Nanoparticle Composite Hydrogel for Anticancer Drug Delivery | |
| Rajamalli et al. | Glucose-cored poly (aryl ether) dendron based low molecular weight gels: pH controlled morphology and hybrid hydrogel formation | |
| EA201070793A1 (ru) | Нанодисперсия | |
| RU2010138925A (ru) | Микрочастица и ее фармацевтическая композиция | |
| Kang et al. | Modulation of cyclic topology toward enhanced drug delivery, from linear and tadpole-like to dumbbell-shaped copolymers | |
| US20090196937A1 (en) | Temperature-sensitive nano-carriers | |
| JP2009527505A5 (OSRAM) | ||
| JP2013528838A5 (OSRAM) | ||
| JP2009074034A5 (OSRAM) | ||
| JP2015513311A5 (OSRAM) | ||
| Noori et al. | Phthalic Anhydride Glycerol as a pore former for enhancing the surface and morphology of PVC ultrafiltration membrane | |
| JP2009155453A5 (OSRAM) | ||
| CN110354072B (zh) | 一种近红外光响应的氧化石墨烯/凹凸棒石复合超分子水凝胶的制备和应用 | |
| Zhou et al. | Synthesis of Ag/fluorine-containing polyacrylate latex stabilized by Ag nanoparticle hybrid amphiphilic random copolymer micelles via Pickering emulsion polymerization and its application on fabric finishing | |
| Li et al. | Facile construction of well-defined fullerene–dendrimer supramolecular nanocomposites for bioapplications |